Login to LiveSLR
Login to MyCytel
Login to CytelStore
Solutions
Drug Development Cycle
Discovery
Phase I-III Clinical Trials
Commercialization
Real-World Evidence Solutions
Strategic Data Science and Analytical Methods
Clinical Trial Design
Trial Delivery
Advanced Analytics
Specialty Areas
Discovery

Our innovative preclinical solutions empower your drug development journey with cutting-edge analytics and insights from inception to preclinical stages.

Find out more
Phase I-III Clinical Trials

We help you navigate complex trial phases efficiently with data-driven methods & strategies tailored to Phase I-III trials for accelerated drug development.

Learn more
Commercialization

Maximize your market potential and optimize your commercial strategies with our advanced analytical methods, data science, and tailored commercialization solutions for data-driven commercial success.

Learn more
Real-World Evidence Solutions

Harness the power of real-world data and real-world evidence to gather insights and shape future drug development cycles for enhanced efficacy and regulatory compliance.

Find out more
Clinical Trial Design

Craft optimal trial designs with our advanced analytical methods to enhance efficiency and increase the probability of success throughout your drug’s lifecycle.

Learn more
Trial Delivery

Empower your trial delivery by transforming trial designs into actionable strategies with our data-driven approach to ensure seamless delivery and successful outcomes.

Find out more
Advanced Analytics

Unlock the power of data with our methods for actionable insights to drive informed decisions and optimize clinical trial outcomes.

Learn more
Specialty Areas

We offer tailored analytics solutions for your specialized or niche projects enabling you to optimize both efficiency and precision in drug development.

Learn more
Quick Links
Data Strategy Model-lnformed Drug Development Chemistry, Manufacturing and Controls (CMC) Toxicology Solutions Clinical Pharmacology, Drug Metabolism and Pharmacokinetics
Adaptive Trial Designs Complex and Innovative Trial Design Model-lnformed Drug Development Clinical Development Strategy and Planning End-to-End Biometrics Axio® Data Monitoring Committee Data Strategy Regulatory Strategy Market Access Real-World Evidence Software for Trial Design
Health Economics and Outcomes Research (HEOR) Market Access Regulatory Strategy Real-World Evidence Health and Technology Assessments stève consultants
Real-World Evidence Real-World Data Real-World Data Software Post-Authorization Safety Studies stève consultants
Adaptive Trial Design Complex and Innovative Trial design Model-lnformed Drug Development Software for Trial Design
End-to-End Biometrics Data Management Early Phase Solutions Late Phase Solutions Axio® Data Monitoring Committee Safety & Regulatory Compliance FSP Outsourcing Outsourcing per Project Software for Trial Implementation
Systematic Literature Reviews Complex and Innovative Trial Design Market Access Health Economics & Outcomes Research Real-World Evidence Real-World Data Health and Technology Assessments
Synthetic Controls External Controls Rare Diseases Oncology Post-Authorization Safety Studies Decentralized Trials Pediatrics
Delivery Models
Strategic Consulting
Beyond Functional Service Provider
Project-Based Analytical Solutions
Software Solutions
Trial Design Software
Trial Implementation and Decision Support Software
LiveSLR® Software for Systematic Literature Reviews
Strategic Consulting

Enhance your clinical trial design with our strategic consulting services, featuring adaptive trial models and comprehensive regulatory guidance to ensure innovative, compliant, and successful trial outcomes.

Learn more
Beyond Functional Service Provider

Experience the future of flexible strategic partnerships with Analytics on Demand, providing adaptive and innovative solutions that transcend traditional models to achieve unparalleled operational excellence.

Learn more
Project-Based Analytical Solutions

Maximize efficiency and outcomes with our project-based services, delivering specialized expertise, end-to-end biometrics, and focused solutions for unique projects, ensuring timely completion and exceptional results.

Project-Based Analytical Solutions
Trial Design Software

Cytel's software platform enables precise trial design and simulation, utilizing adaptive and Bayesian tools to optimize protocols and accelerate drug development with confidence and efficiency.

Learn more
Trial Implementation and Decision Support Software

Our unique software package streamlines trial implementation with intuitive solutions for protocol development, randomization, and patient management, optimizing operational efficiency and ensuring study success.

Learn more
LiveSLR® Software for Systematic Literature Reviews

Learn more
Quick Links
Adaptive Trial Designs Advanced Analytics Regulatory Strategy Clinical Development Strategy & Planning Discovery and Pre-clinical Clinical Pharmacology, drug metabolism and pharmacokinetics
Staff Augmentation Strategic Capacity Management Functional Service Provider Hybrid FSP Model
Data Management End-to-End Biometrics Data Submission support Axio® Data Monitoring Committee Medical Writing
East Horizon™ Platform for Trial Design Xact software suite, StatXact®
Enforesys
About Us
About Us

Learn about our rich history, visionary leadership, and core values. Our mission and vision drive us to deliver excellence in drug development globally.

Learn more
Quick Links
Our Experts Leadership Team Innovation Advisory Board
 
Board of Directors Sustainability
Insights
Insights

Explore Cytel’s Insights hub - your source for the latest news, event updates, and expert insights on advanced data analytics and data science.

Explore now
Quick Links
Perspectives News and Events Resource Library Publications
 
Careers
Careers

Join our innovative team at Cytel! Explore exciting career opportunities in data science and statistics, analytical methods, and regulatory strategy. Advance the future of human health with us.

Learn more
Quick Links
Connect with Us Join our Talent Network Find our Latest Opportunities
 
Contact Us
Contact us
Contact Us
Customer Support
Customer Support
Login to LiveSLR
Login to MyCytel
Login to CytelStore
Contact us
Contact Us
Customer Support
Customer Support

Testing One Primary and Two Secondary Endpoints in a Two-Stage Group Sequential Trial With Extensions. Tamhane AC, Xi D, Mehta CR, Romanenko A, Gou J. Stat Med. 202

Real-world experience with filgotinib for rheumatoid arthritis in Germany : A retrospective chart review. Schultz O, Fiehn C, Kneitz C, Picker N, Kromer D, Zignani M, De Leonardis F, Orzechowski HD, Gurrath M, Krüger K. Z Rheumatol. 2025

The effect of prenatal balanced energy and protein supplementation on gestational weight gain: An individual participant data meta-analysis in low- and middle-income countries. Wang D, Partap U, Liu E, Costa JC, Cliffer IR, Wang M, Nookala SK, Subramoney V, Briggs B, Ahmed I, Argaw A, Ariff S, Bhandari N, Chowdhury R, Erchick D, García-Guerra A, Ghaffarpour M, Hanley-Cook G, Huybregts L, Jehan F, Kaseb F, Krebs NF, Lachat C, Lama TP, Manandhar DS, McClure EM, Moore SE, Muhammad A, Neufeld LM, Prentice AM, Quezada-Sánchez AD, Roberfroid D, Saville NM, Shafiq Y, Shrestha BP, Sonko B, Soofi S, Taneja S, Tielsch JM, Toe LC, Valaei N, Fawzi WW. PLoS Med. 2025

Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort. Disanto G, Schaedelin S, Oechtering J, Lorscheider J, Galbusera R, Finkener S, Achtnichts L, Lalive P, Müller S, Pot C, Hoepner R, Salmen A, Zecca C, Hemkens LG, D’Souza M, Fischer-Barnicol B, Du Pasquier R, Roth P, Yaldizli Ö, Einsiedler M, Derfuss T, Kappos L, Gobbi C, Granziera C, Uginet M, Maceski AM, O’Neill K, Leppert D, Benkert P, Kuhle J; Swiss MS Cohort Study. Mult Scler J Exp Transl Clin. 2025

Long-Term Safety and Efficacy of Esmethadone in Patients With Major Depressive Disorder: Findings From a 12-Month Open-Label Study. Fava M, Pani L, De Martin S, Cutler AJ, Gorodetzky CW, Vocci FJ, Sapienza FL, Kosten TR, Kröger C, Champasa P, Guidetti C, Comai S, Mattarei A, Folli F, Bushnell D, Traversa S, Inturrisi CE, Manfredi PL, Pappagallo M. J Clin Psychiatry. 2025

Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma. Ramaswami R, Kask AS, D’Amico L, Menon MP, Lurain K, Yarchoan R, Ekwede I, Couey P, Burnham E, Angeldekao A, Ha Lee B, Kaiser JC, Cheever M, Uldrick TS, Kwok LL, Wright A, Fling SP, Wang CJ. J Immunother Cancer. 2025

Matching-Adjusted Indirect Comparison of Daratumumab-Pomalidomide-Dexamethasone and Pomalidomide-Bortezomib-Dexamethasone in Relapsed/Refractory Multiple Myeloma. Chng WJ, Wu DB, Wu CK, Springford A, Daly CH, Jung SH. Clin Lymphoma Myeloma

Serum levels of hepatitis B core antibodies and hepatitis B core-related antigen at the time of nucleos(t)ide analog cessation and risk of severe flares in patients with chronic hepatitis B. van Bömmel F, Verbinnen T, Agarwal K, Vanwolleghem T, Lampertico P, Buti M, Janczewska E, Bourliere M, Jezorwski J, Donohue K, Kim G, Kakuda TN, De Meyer S, Bakala A, Biermer M, Lenz O. Hepatol Commun. 2025

Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study. Wiendl H, Barkhof F, Montalban X, Achiron A, Derfuss T, Chan A, Hodgkinson S, Prat A, Leocani L, Schmierer K, Sellebjerg F, Vermersch P, Jin H, Chudecka A, Kloetgen A, Lin D, Gardner L, De Stefano N. Front Immunol. 2025

Real-world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes. O’Donnell HK, Simmons KM, Gitelman SE, Dex T, Hill R, Wieloch M, Zaccai J, D’Souza J, Ginchereau Sowell F, Turnbull J, Hood KK. Diabetes Obes Metab. 2025

Newer Posts
Older Posts